A notice issued to the foreign journalists on Wednesday said they can get the Inactivated SARS-CoV-2 Vaccine, developed by Sinopharm's China National Biotec Group. Sinopharm's COVID-19 vaccine has been granted conditional market approval by China's National Medical Products Administration.
The approval comes a day after Sinopharm said its vaccine showed 79.34 per cent efficacy and a 99.52 per cent antibody-positive conversion rate in the interim results of the Phase III clinical trials.
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the United States drug regulator on Sunday.
Gates, who is to attend the World Economic Forum's Annual Meeting, on Monday said there is reason to be optimistic than ever about the future progress using vaccines to give all children a healthy start to life.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances